Sheldon Koenig, MBA in

Sheldon Koenig, MBA

Login to view DISC.
Board Member & Co-Founder at Nuvig Therapeutics Inc.
📍 Washington, District of Columbia, United States

Sheldon Koenig is the President and CEO of Esperion and a Co-Founder of Nuvig Therapeutics. With over two decades of executive experience at Merck and Sanofi, he specializes in global marketing, commercialization, and market access for biotech innovations. People who have worked with him describe him as a "smart" and "savvy" marketer.

He is dedicated to advancing the pharmaceutical industry and expressed a desire for professionals in the field to continue bringing great medicine and research forward. He values a collaborative team approach and engaging with both current and future investors to share compelling company stories.

He has deep expertise in managing all phases of clinical trials (I-V) and possesses extensive knowledge of U. S. reimbursement and global payor strategies.

Read the full overview →
Experience
9 Years
Current Role
Board Member & Co-Founder
Job Level
Leadership
Location
Washington, District of Columbia, United States
Personality Overview

How Sheldon shows up

Communication Style
Decision Approach
Work Preference

Behavioral traits and communication patterns that shape how this person evaluates opportunities, builds trust, and makes decisions in professional settings.

Login to view personality overview.
Priorities

Topics Sheldon cares about

Biotech Commercialization
His career focuses on propelling product innovation, market access, and sales growth for pharma and biotech companies on a global scale.
Cardiovascular Health
As CEO of Esperion, he leads a company focused on developing and commercializing medicines for patients with elevated LDL-C and cardiovascular disease.
+5 more topics Login to view topics
Career

Work history

11-2021
Board Member & Co-Founder
Nuvig Therapeutics Inc.
5-2021
President and CEO of Esperion Therapeutics
Esperion
12-2020 - 5-2021
Chief Operating Officer
Esperion
1-2019 - 8-2020
Executive Vice President and Chief Commercial Officer
Portola Pharmaceuticals
7-2018 - 12-2018
President
SL Koenig & Associates, LLC
In the press

Media appearances

Sheldon Koenig, MBA - Nuvig Therapeutics Inc.. Featured in TheOrg.com
See now
Education
Bachelor of Applied Science (B.A.Sc.)
Drexel University
MBA
Monmouth University
Social presence
in
Behavioral profile

DISC profile (public)

DISC behavioral profile

Dominance, influence, steadiness, and calculativeness scores with guidance on how this person prefers to communicate and decide.

Login to view DISC.

More profiles

Discover additional public profiles from our index.

Unlock the full playbookSee exactly how to sell to Sheldon. Free, 10 seconds.